Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Getting To $80 Bil.: PhRMA Expects Mix Of Rebates And Fees In Finance Bill

Executive Summary

The Pharmaceutical Research and Manufacturers of America is expecting to make good on its pledge to contribute $80 billion to health care reform through a combination of drug rebates and fees, in addition to savings from follow-on biologics and the previously announced 50 percent discount on drugs used in the Medicare Part D donut hole

You may also be interested in...



Schumer Wants To Up Pharma Reform Ante To $106 Bil. Via Medicare Rebates

Sen. Chuck Schumer is looking to revive the idea of getting more savings from the pharmaceutical industry than the $80 billion already pledged toward health reform and is eyeing Senate floor debate as the venue

Schumer Wants To Up Pharma Reform Ante To $106 Bil. Via Medicare Rebates

Sen. Chuck Schumer is looking to revive the idea of getting more savings from the pharmaceutical industry than the $80 billion already pledged toward health reform and is eyeing Senate floor debate as the venue

Sen. Schumer Wants Pharma's Health Reform Contribution Upped To $106 Bil. Via More Medicare Rebates

Schumer suggests pharma contribution could resurface during Senate floor debate on health reform.

Related Content

Topics

UsernamePublicRestriction

Register

MT125529

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel